Clinical Study to Evaluate the Efficacy of Topical Medications Containing Benzoyl Peroxide and Sulfur in the Regression in the Short Time (24 Hours) of Moderate Acne Vulgaris Grade II (Pimples)
NCT ID: NCT01260571
Last Updated: 2010-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
62 participants
INTERVENTIONAL
2011-01-31
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A follow-up visit will be made 24 hours after initiation of treatment.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Benzoyl Peroxide and Sulfur
Topical Medications containing benzoyl peroxide and sulfur
Benzoyl peroxide and sulfur
topical cream, 5% benzoyl peroxide and 2% sulfur Frequency once to day Duration 24 hours
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Benzoyl peroxide and sulfur
topical cream, 5% benzoyl peroxide and 2% sulfur Frequency once to day Duration 24 hours
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Oily skin prone to acne
* Presence of at least three inflammatory lesions, diagnosed as grade II acne vulgaris.
* Sign the informed Consent Form
* Comply the requirements and attend to study visits
Exclusion Criteria
* Lactation
* Presence of acne conglobata and nodulocystic
* Pathologies associated hormonal (thyroid diseases, ovaries micropolycystic)
* Drug use systemic corticosteroids, anticonvulsants and / or new drugs for up to one month before to selection.
* History of atopy or allergic cutaneous
* History of hypersensitivity to benzoyl peroxide and sulfur
* Beginning or ending the use of contraceptives (for females)
* Intense sun exposure until one month before the evaluation
12 Years
35 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zurita Laboratorio Farmaceutico Ltda.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Medicin Skin Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medcin Instituto da Pele
Osasco, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Sergio Schalka, Doctor's
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EAA 554-10/v6
Identifier Type: -
Identifier Source: org_study_id